CYRX - CryoPort GAAP EPS of -$0.16 beats by $0.07 revenue of $63M beats by $0.85M
2023-05-04 16:29:07 ET
- CryoPort press release ( NASDAQ: CYRX ): Q1 GAAP EPS of -$0.16 beats by $0.07 .
- Revenue of $63M (+20.5% Y/Y) beats by $0.85M .
-
- Outlook
- The Company's revenue guidance of $270 - $290 million vs $273.57M consensus for the full year 2023 is expected to be driven largely by our ongoing support of global clinical trials, a growing number of commercial cell and gene therapy products from our clients, the expansion of cell and gene manufacturing capacity to meet patient demand, and the demand for biostorage and cryogenic freezer systems. Our 2023 guidance also assumes the launch of new services and products, designed to further expand, and strengthen our industry position.
For further details see:
CryoPort GAAP EPS of -$0.16 beats by $0.07, revenue of $63M beats by $0.85M